Citadel Advisors - OSIRIS THERAPEUTICS INC NEW ownership

OSIRIS THERAPEUTICS INC NEW's ticker is OSIR and the CUSIP is 68827R108. A total of 67 filers reported holding OSIRIS THERAPEUTICS INC NEW in Q4 2013. The put-call ratio across all filers is 2.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of OSIRIS THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2016$127,000
-55.1%
25,742
-5.9%
0.00%
Q4 2015$283,000
-28.5%
27,350
+34.5%
0.00%
Q2 2015$396,000
-82.3%
20,330
-84.0%
0.00%
-100.0%
Q1 2015$2,240,000
+613.4%
127,368
+549.1%
0.00%
Q4 2014$314,000
-19.9%
19,622
-37.0%
0.00%
Q3 2014$392,000
+36.6%
31,164
+70.0%
0.00%
Q2 2014$287,000
-21.8%
18,328
-34.5%
0.00%
Q1 2014$367,000
-32.7%
27,967
-17.5%
0.00%
-100.0%
Q4 2013$545,000
+378.1%
33,918
+393.5%
0.00%
Q3 2013$114,000
-54.6%
6,873
-72.3%
0.00%
Q2 2013$251,00024,8500.00%
Other shareholders

There were no reported owners of OSIRIS THERAPEUTICS INC NEW in Q4 2013.

NameSharesValueWeighting ↓
View complete list of OSIRIS THERAPEUTICS INC NEW shareholders